December 8, 2025Blood

Survival outcomes in therapy-related acute lymphoblastic leukemia: A population-based analysis from SEER (2000–2022)

View Full Paper

Ask AI

Bookmark

Survival predictors indicate that older age significantly correlates with higher mortality in patients with t-ALL, revealing age's impact on outcomes.
The cohort analysis captured 2,317 patients, showing that adolescents and young adults represent only 13.1% of cases, with most patients aged 60 or older.
Data were extracted from the SEER 17 registries, employing Kaplan-Meier methods to assess overall survival and Cox models for mortality predictors.
Findings emphasize a need for age-specific treatment strategies, highlighting the distinct nature of t-ALL as a high-risk subgroup in clinical settings.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Population-based analysis reveals cytotoxic treatment leads to poor prognosis in older adults with t-ALL, suggesting targeted treatment strategies are essential.

Cite This Study

Shah et al. (2025) studied this question.

synapsesocial.com/papers/69362f634fa91c937236de68 https://doi.org/10.1182/blood-2025-1560

View Full Paper

Ask AI

Bookmark

Implication

Population-based analysis reveals cytotoxic treatment leads to poor prognosis in older adults with t-ALL, suggesting targeted treatment strategies are essential.

Survival outcomes in therapy-related acute lymphoblastic leukemia: A population-based analysis from SEER (2000–2022)

Key Points

Discussion

Implication

Cite This Study

Survival outcomes in therapy-related acute lymphoblastic leukemia: A population-based analysis from SEER (2000–2022)

Key Points

Discussion

Implication

Cite This Study